genedrive plc is focused on decentralising molecular diagnostics, concentrating on applications where our technology will provide sustainable growth
Diagnostics: Rapid and accurate diagnosis of infectious disease facilitating immediate therapeutic treatment.
Pharmacogenomics: Allowing medicine to be personalised around an individual patient's genotype.
Future applications: Genedrive® is being validated for use in the areas of pathogen detection & biosurveillance and aquaculture.
genedrive plc at a glance >
Share price details >
View all regulatory news >
31 March 2022
Interim Presentation 31 December 2021
View all reports >
Monday May 30, 2022
Genedrive gets UK coronavirus test device approval
Friday April 01, 2022
Inspiration Healthcare and genedrive launch test for neonatal hearing loss risk
Tuesday March 29, 2022
McKay Securities reveals possible rival to agreed offer from Workspace
View all news >
On the 8th June 2018 Genedrive Plc disposed of the business and assets of Epistem Ltd. Please follow this link to be redirected to the website of Epistem Ltd
© 2017-22 genedrive plc
Don't show this again